• OPEN AN ACCOUNT
Indian Indices
Nifty
26,215.55 10.25
(0.04%)
Sensex
85,706.67 -13.71
( -0.02%)
Bank Nifty
59,737.30 209.25
( 0.35%)
Nifty IT
37,446.30 81.70
( 0.22%)
Global Indices
Nasdaq
47,448.12 314.66
(0.67%)
Dow Jones
6,833.61 46.73
(0.69%)
Hang Seng
50,220.95 53.85
(0.11%)
Nikkei 225
9,688.31 -3.27
(-0.03%)
Forex
USD-INR
89.20 0.05
(0.06%)
EUR-INR
103.32 0.40
(0.39%)
GBP-INR
117.74 0.57
(0.49%)
JPY-INR
0.57 0.00
(0.07%)

EQUITY - MARKET SCREENER

Mahindra & Mahindra Ltd
Industry :  Automobiles - Passenger Cars
BSE Code
ISIN Demat
Book Value()
500520
INE101A01026
534.8629059
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
M&M
32.69
457811.36
EPS(TTM)
Face Value()
Div & Yield %
112.61
5
0.66
 

Natco Pharma concludes USFDA inspection of its API unit in Chennai
Nov 21,2025

Natco Pharma today announced conclusion of US FDA Inspection at its Manali, Chennai, Active Pharmaceutical Ingredients (API) Unit. The inspection was conducted from 17 - 21 November 2025.

On conclusion of the inspection, the Company received seven observations in the Form-483. The Company believes that the observations are procedural in nature. The Company is confident to address these observations comprehensively.